• Blogs
  • Ola Bloch
  • Ed inside a mystery inside an enigma". J Clin Endocrinol Metab

Ed inside a mystery inside an enigma". J Clin Endocrinol Metab

Fraser HM, Wulff C: L-685458 Purity PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/27741243 Angiogenesis in the corpus luteum. Artini PG, Monti M, Matteucci C, Valentino V, Cristello F, Genazzani AR: Vascular endothelial growth element and fundamental fibroblast growth issue in polycystic ovary syndrome during controlled ovarian hyperstimulation. Gynecol Endocrinol 2006, 22(8):465?70. 11. Amin AF, Abd el-Aal DE, Darwish AM, Meki AR: Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial development element, and insulin-like development factor-1 in ladies with polycystic ovary syndrome. Fertil Steril 2003, 79(four):938?41. 12. Artini PG, Ruggiero M, Parisen Toldin MR, Monteleone P, Monti M, Cela V, Genazzani AR: Vascular endothelial development issue and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF. Hum Fertil (Camb) 2009, 12(1):40?4. 13. Carmeliet P: Angiogenesis in overall health and disease. Nat Med 2003, 9(six):653?60. 14. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD: Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000, six(4):460?63. 15. Maisonpierre Computer, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al: Angiopoietin-2, a organic antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277(5322):55?0. 16. Yancopoulos GD, Davis S, Gale NW, Rudge JS, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/25681438 Wiegand SJ, Holash J: Vascular-specific growth things and blood Nutlin (3a)Purity & Documentation vessel formation. Nature 2000, 407(6801):242?48. 17.Ed inside a mystery inside an enigma". J Clin Endocrinol Metab 2009, 94(six):1883?885. 2. Qiao J, Feng HL: Extra- and intra-ovarian things in polycystic ovary syndrome: influence on oocyte maturation and embryo developmental competence. Hum Reprod Update 2011, 17(1):17?three. 3. Fraser HM, Wulff C: PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/27741243 Angiogenesis within the corpus luteum. Reprod Biol Endocrinol 2003, 1:88. four. Hazzard TM, Christenson LK, Stouffer RL: Alterations in expression of vascular endothelial development factor and angiopoietin-1 and -2 within the macaque corpus luteum throughout the menstrual cycle. Mol Hum Reprod 2000, 6(11):993?98. 5. Wulff C, Wilson H, Largue P, Duncan WC, Armstrong DG, Fraser HM: Angiogenesis inside the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth issue messenger ribonucleic acid. J Clin Endocrinol Metab 2000, 85(11):4302?309. 6. Sugino N, Suzuki T, Sakata A, Miwa I, Asada H, Taketani T, Yamagata Y, Tamura H: Angiogenesis in the human corpus luteum: modifications in expression of angiopoietins within the corpus luteum throughout the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 2005, 90(11):6141?148. 7. Geva E, Jaffe RB: Role of vascular endothelial development factor in ovarian physiology and pathology. Fertil Steril 2000, 74(three):429?38. eight. Ferrara N, Frantz G, LeCouter J, Dillard-Telm L, Pham T, Draksharapu A, Giordano T, Peale F: Differential expression from the angiogenic aspect genes vascular endothelial development factor (VEGF) and endocrine glandderived VEGF in regular and polycystic human ovaries. Am J Pathol 2003, 162(six):1881?893.